DEBRA MANGRUM: Open Payments
NPI 1669917654 · OLYMPIA FIELDS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,141 in 107 payments from 20 companies in 2025. Trend: 2023 $1,747 · 2024 $2,276 · 2025 $2,141
Food & beverage: $2,141
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 9 | $228 |
| Actelion Pharmaceuticals US, Inc. | 17 | $218 |
| Novo Nordisk Inc | 7 | $210 |
| AstraZeneca Pharmaceuticals LP | 9 | $200 |
| Amgen Inc. | 11 | $185 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $172 |
| PFIZER INC. | 9 | $172 |
| Novartis Pharmaceuticals Corporation | 9 | $161 |
| Boston Scientific Corporation | 7 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $98 |
Products named: OPSUMIT, Wegovy, WAINUA, REPATHA, LifeVest, LEQVIO, VYNDAQEL, AMVUTTRA.
Industry payments across IL — which companies pay providers there.
